Trial NCT05394350

View at ClinicalTrials.gov 
Org. Study IDs: 1088-002
Secondary IDs: 2021-006712-93 MK-1088-002

Last trial update was posted on 2023-09-14

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasms

Other Conditions

Advanced Solid Tumors

Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID